Genotoxicity and cellular uptake of cyclotides: Evidence for multiple modes of action

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 747, Issue 2, 2012, Pages 176-181

  Yeshak, Marimawit Y ^a,b   Göransson, Ulf ^a   Burman, Robert ^a   Hellman, Björn ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Comet assay; Cyclotides; Cycloviolacin O2; Kalata B1; Micro autoradiography; Vaby D

Indexed keywords

AMINO ACID; CYCLOTIDE; CYCLOVIOLACIN OXYGEN; KALATA B1; TRITIUM; UNCLASSIFIED DRUG; VABY D; VEGETABLE PROTEIN;

ARTICLE; AUTORADIOGRAPHY; CELL MEMBRANE; COMET ASSAY; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DISULFIDE BOND; DNA DAMAGE; DNA FRAGMENTATION; DOSE RESPONSE; DRUG INDUSTRY; GENOTOXICITY; HUMAN; HUMAN CELL; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; COMET ASSAY; CYCLOTIDES; DNA DAMAGE; HUMANS; MODELS, MOLECULAR;

EID: 84863780710     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.05.006     Document Type: Article

References (51)

1. Craik D.J., Daly N.L., Bond T., Waine C. Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol. 1999, 294:1327-1336.
2. Colgrave M.L., Craik D.J. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 2004, 43:5965-5975.
3. Göransson U., Craik D.J. Disulfide mapping of the cyclotide kalata B1: chemical proof of the cyclic cystine knot motif. J. Biol. Chem. 2003, 278:48188-48196.
4. Rosengren K.J., Daly N.L., Plan M.R., Waine C., Craik D.J. Twists, knots, and rings in proteins. Structural definition of the cyclotide framework. J. Biol. Chem. 2003, 278:8606-8616.
5. Mulvenna J.P., Wang C., Craik D.J. CyBase: a database of cyclic protein sequence and structure. Nucleic Acids Res. 2006, 34:D192-D194.
6. Wang C.K., Kaas Q., Chiche L., Craik D.J. CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res. 2008, 36:D206-D210.
7. Chiche L., Heitz A., Gelly J.C., Gracy J., Chau P.T., Ha P.T., Hernandez J.F., Le-Nguyen D. Squash inhibitors: from structural motifs to macrocyclic knottins. Curr. Protein Pept. Sci. 2004, 5:341-349.
8. Jennings C., West J., Waine C., Craik D.J., Anderson M. Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10614-10619.
9. Trabi M., Svangard E., Herrmann A., Goransson U., Claeson P., Craik D.J., Bohlin L. Variations in cyclotide expression in viola species. J. Nat. Prod. 2004, 67:806-810.
10. Craik D.J., Simonsen S., Daly N.L. The cyclotides: novel macrocyclic peptides as scaffolds in drug design. Curr. Opin. Drug Discov. Devel. 2002, 5:251-260.
11. Leta Aboye T., Clark R.J., Craik D.J., Goransson U. Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. Chembiochem 2008, 9:103-113.
12. Chan L.Y., Gunasekera S., Henriques S.T., Worth N.F., Le S.J., Clark R.J., Campbell J.H., Craik D.J., Daly N.L. Engineering pro-angiogenic peptides using stable disulfide-rich cyclic scaffolds. Blood 2011.
13. Gustafson K.R., Sowder R.C., Henderson L.E., Parsons I.C., Kashman Y., Cardellina J.H., McMahon J.B., Buckheit R.W., Pannell L.K., Boyd M.R. Circulins A and B: novel HIV-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia. J. Am. Chem. Soc. 1994, 116:9337-9338.
14. Colgrave M.L., Kotze A.C., Kopp S., McCarthy J.S., Coleman G.T., Craik D.J. Anthelmintic activity of cyclotides: in vitro studies with canine and human hookworms. Acta Trop. 2009, 109:163-166.
15. Tam J.P., Lu Y.A., Yang J.L., Chiu K.W. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:8913-8918.
16. Pränting M., Lööv C., Burman R., Göransson U., Andersson D.I. The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria. J. Antimicrob. Chemother. 2010.
17. Gran L. Oxytocic principles of Oldenlandia affinis. Lloydia 1973, 36:174-178.
18. Witherup K.M., Bogusky M.J., Anderson P.S., Ramjit H., Ransom R.W., Wood T., Sardana M. Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J. Nat. Prod. 1994, 57:1619-1625.
19. Schöpke T., Hasan Agha M.I., Kraft R., Otto A., Hiller K. Hämolytisch aktive komponenten aus Viola tricolor L. und Viola arvensis Murray. Sci. Pharm. 1993, 61:145-153.
20. Hernandez J.F., Gagnon J., Chiche L., Nguyen T.M., Andrieu J.P., Heitz A., Hong T.T., Pham T.T.C., Nguyen D.L. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry 2000, 39:5722-5730.
21. Plan M.R., Saska I., Cagauan A.G., Craik D.J. Backbone cyclised peptides from plants show molluscicidal activity against the rice pest Pomacea canaliculata (golden apple snail). J. Agric. Food Chem. 2008, 56:5237-5241.
22. Göransson U., Sjögren M., Svangård E., Claeson P., Bohlin L. Reversible antifouling effect of the cyclotide cycloviolacin O2 against barnacles. J. Nat. Prod. 2004, 67:1287-1290.
23. Lindholm P., Göransson U., Johansson S., Claeson P., Gullbo J., Larsson R., Bohlin L., Backlund A. Cyclotides: a novel type of cytotoxic agents. Mol. Cancer Ther. 2002, 1:365-369.
24. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen 2000, 35:206-221.
25. Andersson M., Agurell E., Vaghef H., Bolcsfoldi G., Hellman B. Extended-term cultures of human T-lymphocytes and the comet assay: a useful combination when testing for genotoxicity in vitro?. Mutat. Res. 2003, 540:43-55.
26. Burman R., Stromstedt A.A., Malmsten M., Goransson U. Cyclotide-membrane interactions: defining factors of membrane binding, depletion and disruption. Biochim. Biophys. Acta 2011, 1808:2665-2673.
27. Svangård E., Burman R., Gunasekera S., Lövborg H., Gullbo J., Göransson U. Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranes. J. Nat. Prod. 2007, 70:643-647.
28. Yeshak M.Y., Burman R., Asres K., Goransson U. Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands. J. Nat. Prod. 2011, 74:727-731.
29. Plan M.R., Göransson U., Clark R.J., Daly N.L., Colgrave M.L., Craik D.J. The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides. Chembiochem 2007, 8:1001-1011.
30. Herrmann A., Burman R., Mylne J.S., Karlsson G., Gullbo J., Craik D.J., Clark R.J., Goransson U. The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity. Phytochemistry 2008, 69:939-952.
31. Lindhagen E., Nygren P., Larsson R. The fluorometric microculture cytotoxicity assay. Nat. Protoc. 2008, 3:1364-1369.
32. Andersson M.A., Hellman B.E. Evaluation of catechol-induced DNA damage in human lymphocytes: a comparison between freshly isolated lymphocytes and T-lymphocytes from extended-term cultures. Toxicol. In Vitro 2007, 21:716-722.
33. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
34. Vaghef H., Wisen A.C., Hellman B. Demonstration of benzo(a)pyrene-induced DNA damage in mice by alkaline single cell gel electrophoresis: evidence for strand breaks in liver but not in lymphocytes and bone marrow. Pharmacol. Toxicol. 1996, 78:37-43.
35. Demma J., Engidawork E., Hellman B. Potential genotoxicity of plant extracts used in Ethiopian traditional medicine. J. Ethnopharmacol. 2009, 122:136-142.
36. Hellman B., Vaghef H., Bostrom B. The concepts of tail moment and tail inertia in the single cell gel electrophoresis assay. Mutat. Res. 1995, 336:123-131.
37. Blanchfield J.T., Dutton J.L., Hogg R.C., Gallagher O.P., Craik D.J., Jones A., Adams D.J., Lewis R.J., Alewood P.F., Toth I. Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J. Med. Chem. 2003, 46:1266-1272.
38. Shenkarev Z.O., Nadezhdin K.D., Sobol V.A., Sobol A.G., Skjeldal L., Arseniev A.S. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle. FEBS J. 2006, 273:2658-2672.
39. Huang Y.H., Colgrave M.L., Daly N.L., Keleshian A., Martinac B., Craik D.J. The biological activity of the prototypic cyclotide kalata b1 is modulated by the formation of multimeric pores. J. Biol. Chem. 2009, 284:20699-20707.
40. Kumaravel T.S., Vilhar B., Faux S.P., Jha A.N. Comet assay measurements: a perspective. Cell Biol. Toxicol. 2009, 25:53-64.
41. Hartmann A., Speit G. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol. Lett. 1997, 90:183-188.
42. Kamimori H., Hall K., Craik D., Aguilar M. Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance. Anal. Biochem. 2005, 337:149-153.
43. Herrmann A., Svangård E., Claeson P., Gullbo J., Bohlin L., Göransson U. Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2. Cell. Mol. Life Sci. 2006, 63:235-245.
44. Greenwood K.P., Daly N.L., Brown D.L., Stow J.L., Craik D.J. The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int. J. Biochem. Cell Biol. 2007, 39:2252-2264.
45. Cascales L., Henriques S.T., Kerr M.C., Huang Y.H., Sweet M.J., Daly N.L., Craik D.J. Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides. J. Biol. Chem. 2011, 286:36932-36943.
46. Contreras J., Elnagar A.Y., Hamm-Alvarez S.F., Camarero J.A. Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways. J. Control. Release 2011, 155:134-143.
47. Boya P., Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008, 27:6434-6451.
48. Erdal H., Berndtsson M., Castro J., Brunk U., Shoshan M.C., Linder S. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:192-197.
49. Chugh A., Eudes F., Shim Y.S. Cell-penetrating peptides: nanocarrier for macromolecule delivery in living cells. IUBMB Life 2010, 62:183-193.
50. Gerlach S.L., Rathinakumar R., Chakravarty G., Goransson U., Wimley W.C., Darwin S.P., Mondal D. Anticancer and chemosensitizing abilities of cycloviolacin 02 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Biopolymers 2010, 94:617-625.
51. Göransson U., Herrmann A., Burman R., Haugaard-Jonsson L.M., Rosengren K.J. The conserved glu in the cyclotide cycloviolacin O2 has a key structural role. Chembiochem 2009, 10:2354-2360.